Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Angiotensin-2-Mediated Ca2+ Signaling in the Retinal Pigment Epithelium: Role of Angiotensin-Receptor- Associated-Protein and TRPV2 Channel

  • Rene Barro-Soria,

    Current address: Department of Physiology & Biophysics, University of Miami Miller School of Medicine, Miami, Florida, United States America

    Affiliation Experimental Ophthalmology, Eye Hospital, University Medical Center Regensburg, Regensburg, Germany

    ⨯
  • Julia Stindl,

    Affiliation Experimental Ophthalmology, Eye Hospital, University Medical Center Regensburg, Regensburg, Germany

    ⨯
  • Claudia Müller,

    Affiliation Experimental Ophthalmology, Eye Hospital, University Medical Center Regensburg, Regensburg, Germany

    ⨯
  • Renate Foeckler,

    Affiliation Experimental Ophthalmology, Eye Hospital, University Medical Center Regensburg, Regensburg, Germany

    ⨯
  • Vladimir Todorov,

    Affiliations Institute of Physiology, University of Regensburg, Regensburg, Germany, Laboratory for Experimental Nephrology, Dresden University of Technology, Dresden, Germany

    ⨯
  • Hayo Castrop,

    Affiliation Institute of Physiology, University of Regensburg, Regensburg, Germany

    ⨯
  • Olaf Strauß

    Olaf.Strauss@klinik.uni-regensburg.de

    Affiliation Experimental Ophthalmology, Eye Hospital, University Medical Center Regensburg, Regensburg, Germany

    ⨯

Abstract

Angiotensin II (AngII) receptor (ATR) is involved in pathologic local events such as neovascularisation and inflammation including in the brain and retina. The retinal pigment epithelium (RPE) expresses ATR in its AT1R form, angiotensin-receptor-associated protein (Atrap), and transient-receptor-potential channel-V2 (TRPV2). AT1R and Atrap co-localize to the basolateral membrane of the RPE, as shown by immunostaining. Stimulation of porcine RPE (pRPE) cells by AngII results in biphasic increases in intracellular free Ca2+inhibited by losartan. Xestospongin C (xest C) and U-73122, blockers of IP3R and PLC respectively, reduced AngII-evoked Ca2+response. RPE cells from Atrap−/− mice showed smaller AngII-evoked Ca2+peak (by 22%) and loss of sustained Ca2+elevation compared to wild-type. The TRPV channel activator cannabidiol (CBD) at 15 µM stimulates intracellular Ca2+-rise suggesting that porcine RPE cells express TRPV2 channels. Further evidence supporting the functional expression of TRPV2 channels comes from experiments in which 100 µM SKF96365 (a TRPV channel inhibitor) reduced the cannabidiol-induced Ca2+-rise. Application of SKF96365 or reduction of TRPV2 expression by siRNA reduced the sustained phase of AngII-mediated Ca2+transients by 53%. Thus systemic AngII, an effector of the local renin-angiotensin system stimulates biphasic Ca2+transients in the RPE by releasing Ca2+from cytosolic IP3-dependent stores and activating ATR/Atrap and TRPV2 channels to generate a sustained Ca2+elevation.

Citation: Barro-Soria R, Stindl J, Müller C, Foeckler R, Todorov V, Castrop H, et al. (2012) Angiotensin-2-Mediated Ca2+ Signaling in the Retinal Pigment Epithelium: Role of Angiotensin-Receptor- Associated-Protein and TRPV2 Channel. PLoS ONE 7(11): e49624. https://doi.org/10.1371/journal.pone.0049624

Editor: Michael E. Boulton, University of Florida, United States of America

Received: July 15, 2012; Accepted: October 10, 2012; Published: November 20, 2012

Copyright: © 2012 Barro-Soria et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: Deutsche Forschungsgemeinschaft SFB 699, TPB8 ProRetina PhD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Competing interests: The authors have declared that no competing interests exist.

Introduction

The classical view of the Renin-Angiotensin System (RAS) as a systemic regulator of blood pressure has been extended, and a substantial number of studies have highlighted the importance of local RAS in a variety of extra-renal tissues, including adrenal glands [1], thymus [2] and recently in the eye [3], [4]. In the eye, angiotensin II type 1 receptors (AT1R) have been found in the retina, particularly in Müller cells, amacrine cells, photoreceptors, choroid and in the retinal pigment epithelium (RPE) [5]–[8]. Similarly, studies in rat retinal tissues also suggested local synthesis of both renin and angiotensin converting-enzyme (ACE) [9]. Along this line, Milenkovic et al. (2010) demonstrated that the RPE expresses renin and secretes it towards the retinal side. The presence of the most important RAS components in the retina implies a physiological function of RAS within the eye. However, despite the considerable evidence for local RAS in the retina, its exact role and its possible relationship with the systemic RAS remain poorly understood.

Angiotensin II (AngII) mediates its biological effects through the activation of AT1R and angiotensin II type 2 (AT2R) receptors. It is, however, through AT1R activation that AngII elicits most of its well known effects, including vasoconstriction, electrolyte homeostasis, fibrosis, inflammation and proliferation. In the eye, AT1R activation has been implicated in the pathogenesis of many ocular disorders such as diabetic retinopathy [10], [11], neovascularization in hypoxic-induced retinopathies [12]–[14] and age-related macular degeneration [15]–[17].

In addition, proteins that directly interact with AT1R have received considerable attention because of their crucial roles in the first steps in signal transduction. Among them, the angiotensin receptor-associated protein (Atrap) is the best described [18]. Based on the data published so far, it appears that Atrap functions as a negative modulator of AT1R in the renal tubules [19], [20].

The RPE plays an important role in maintaining retinal function by transporting nutrients, isomerizing all-trans to 11-cis retinal, and phagocytosing shed photoreceptor outer segments [21]. By its anatomical location, the RPE forms the interface between the retina and the blood supply from the choroid and represents a part of the blood-retinal barrier. This makes the RPE suitable to serve as a mediator for transfer of molecules and signals between the blood and the outer retina. The fact that AT1R is localized at the basolateral membrane [7], which faces the blood side of the epithelium, suggests that the activity of the systemic RAS is a part of that signaling. Interestingly, it has been shown that modulation of the systemic RAS (e.g. by systemic application of ACE inhibitors) changes neuronal activity within the retina, mainly of bipolar cells and amacrine cells as monitored by electroretinography [8], [22], [23]. Moreover, modulators of the systemic RAS alter renin expression in the RPE [7] and plasma AngII can not cross the intraocular space [24]. These findings suggest that the systemic RAS most likely influences the intraocular RAS through the RPE.

However, how the RPE would accomplish AT1R-dependent signaling transduction is unknown. It has been proposed that activation of AT1R by AngII triggers a variety of complex intracellular signaling events, such as activation of phospholipase-D [25], induction of phospholipase-C-γ (PLC) phosphorylation or activation of Gq protein-linked to PLC/inositol-1,4,5-trisphosphate (IP3), this last causing transient release of Ca2+from the endoplasmic reticulum (ER) [26]. The concept of store-operated transmembrane Ca2+entry during AngII stimulation in juxtaglomerular cells is well established [27], [28]. Other studies suggest the participation of voltage-activated calcium channels [29] or store-independent calcium-activated Ca2+channels [30] in mediating the influx of Ca2+by AngII. However, the identity of molecules responsible of such Ca2+influx remains controversial. In the RPE, different Ca2+channel types are functionally expressed potentially enabling the AngII-mediated Ca2+entry such as CaV1.3, Orai, (transient-receptor-potential channel) TRPC1/4 and TRPV2 [31]–[33]. Among them, only TRPV2 channels were reported to be linked to a G-protein-coupled receptor and PLC coupled pathway [34]. For this reason, TRPV2 channels are attractive candidates to mediate AngII-elicited Ca2+responses.

In contrast to the pathology role of the RAS in the retina, which is well characterized, its physiological function is less understood [8]. The present study aimed to clarify the molecular mechanism by which systemic AngII modulates the RAS in the eye. Here, we present evidence that the transient-receptor-potential channel-V2 (TRPV2) and Atrap constitute important factors in the complex AngII-mediated signaling pathway in the RPE.

Methods

Animals and Ethical Approval

Atrap knockout (Atrap−/−) adult mice (C57BL/6x129SvEv) from a local colony were used in the study. (Oppermann et al., 2010). Atrap−/− and Atrap+/+littermates were used from heterozygous breeding pairs. All experimental procedures were performed following the guidelines approved by the Institutional Animal Care and Use Committee at University of Regensburg and the Association for Research in Vision and Ophthalmology (ARVO) statement for the use of animals in vision research. All animal experiments were formally approved by the German authorities (Regierung Oberpfalz) under the number 54-2532.1-06/10.

Reverse Transcriptase-PCR (RT-PCR) Analysis

Expression of angiotensin receptor isoforms, Atrap and TRPV2 in cultured (mouse or porcine) RPE, retina, kidney and lung was carried out by isolation of total RNA either from cultured cells or from the corresponding tissues using the NucleoSpin RNAII kit (Macherey-Nagel, Düren, Germany). Reverse transcription was assessed using the RevertAid M-MuLV reverse transcriptase (Fermentas, St.Leon-Rot, Germany). Table 1 shows the oligonucleotide primers designed for detection of mRNA by PCR (gene, accession number, species oligonucleotide sequence 5′-3′ and size of PCR product). PCRs were performed at 94°C for 2 min, for 35 cycles at 94°C for 30 s, and at annealing temperatures of 57°C for 30 s and 72°C for 30 s. PCR products were visualized by loading onto agarose gels.

thumbnail
Download:
Table 1. Oligonucleotide primer sequences for RT-PCR and real -time quantitative RT-PCR.

https://doi.org/10.1371/journal.pone.0049624.t001

Immunohistochemistry

After killing the mice, one eye from each subject was dissected and fixed in 4% (wt/vol) paraformaldehyde for 2 h at room temperature. Immunolabeling was performed on 3-µm paraffin sections, dewaxed, and treated in citrate buffer (citric acid trisodium salt: 1 mM; citric acid monohydrate: 0.2 mM) pH 6.0. Sections were incubated for 5 min in phosphate-buffered saline (PBS) containing Tween 0.2% pH 7.2 (PBS-Tween). Sections were permeabilized with blocking/permeabilization solution [10% (vol/vol), normal goat serum and 0.5% (vol/vol) Triton X-100 in 1×PBS] for 20 min. After three washing steps with PBS, eye sections were then labeled overnight at 4°C with anti-angiotensin II type 1 receptor (AT1R) antibody (ab18801; Abcam, Cambridge, UK) diluted 1∶100 or with anti-Atrap antibody [19], [20], diluted 1∶200 in 2% normal goat serum and 0.1% Triton X-100 in 1×PBS, pH 7.4. After three additional washing steps, sections were incubated for 1.5 h with secondary antibody conjugated with Alexa 488. (Invitrogen, Karlsruhe, Germany). Sections were mounted in confocal matrix (Micro Tech Lab, Graz, Austria) and examined on a Zeiss Axiovert 135 M microscope attached to a LSM 410 confocal laser scanning system (Carl Zeiss, Göttingen, Germany).

Western Blotting

Western Blot analysis was performed as previously described in detail [35]. Cells were washed with PBS at 4°C three times followed by a centrifugation step of 5 min at 1000 g. The pellet was suspended in PBS-SDS buffer containing β mercaptoethanol (1∶100), a cocktail of protease inhibitors, tris-HCl pH 6.8, and glycerol [35], followed by ultrasound treatment twice for 10 seconds. Proteins were then heated at 90°C for 5 min and subjected to SDS-PAGE (10% gel). Proteins were blotted to a polyvinylidene difluoride membrane (GE Healthcare, Amersham Hybond-P). The blots were blocked in 5% nonfat dried milk in PBS/Tween 20 (0.05%) buffer for 1 h at room temperature. Primary antibodies were diluted as follows: anti-AT1R (1∶500), anti-Atrap (1∶500), anti-TRPV2 (1∶50) anti-β-actin (1∶5000). After overnight incubation at 4°C with primary antibodies, proteins were visualized using a horseradish peroxide-conjugated goat anti-rabbit- or anti-mouse- IgG secondary antibody (1∶5000; Cell Signaling Technology) and a Pierce ECL Western blotting substrate detection kit (Thermo Scientific). The images were digitized using an image analyzer (Alpha Innotech, FluorChemFC2). Each western blot experiment was repeated at least three times with different protein extracts. Densitometry was performed using the densitometry tool of the AlphaEase (FluorChemFC2) software which is implemented in the image analyzer software kit. Densitometric analysis was performed within the same blot using background substraction.

Primary Culture of RPE Cells

Culture of mouse primary RPE cells (passage 0) was performed as described previously by [36]. Briefly, eyes from mice (2–3 months old) were enucleated, opened by a cut along the ora serrata and incubated in PBS-Ca2+/Mg2+free (Buffer I) for 20 min at 37°C. Eyes were transferred to buffer II (buffer I, 1 mM EDTA) for 25 min at 37°C. The retinae were carefully removed from the RPE in buffer I and the eye cups were transferred into the activated enzyme solution [buffer II, 1 U/ml papain (Sigma- 121 Aldrich), 3 mM L-cystein (Sigma-Aldrich) and 1 mg/ml 122 BSA (Sigma-Aldrich)]. After incubation for 23 min at 37°C, RPE cells were isolated and collected in culture medium (Hams/F-12/DMEM (PAA)): 10% fetal calf serum (PAA), 1% penicillin/streptomycin (PAA), 0.5 µl/ml insulin transferring selenium A (GIBCO), 1% nonessential amino acids (PAA) and 5 mM Hepes solution (PAA)] and maintained at 37°C and 5% CO2. Within 7 to10 days, cells from wild-type and Atrap−/− mice were all densely pigmented, showed uniform cubical morphology and were ready to use.

Culture of porcine primary RPE cells (passage 0) was performed as described previously by [7]. The eyes were opened by an incision along the ora serrata. The anterior parts of the eye including the retina were removed. Sheets of RPE cells were harvested in DMEM medium containing L-glutamine, 4.5 g/l glucose, and 110 mg/l sodium pyruvate, supplemented with 20% FCS, 100,000 U/l penicillin, and 100 mg/l streptomycin. RPE cells were suspended into a single suspension and plated out onto glass cover-slips. After 1–2 weeks, the cells formed a confluent monolayer of epithelial cells.

During the recording, unless otherwise specified, cells were bathed in Ringer’s solution composed of the following (in mM): 145 NaCl, 0.4 KH2PO4, 1.6 K2PO4, 5 glucose, 1 MgCl2, and 1.3 Ca2+-gluconate pH 7.4 (310–320 mOsm). AngII, U73122∶1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione, U73343∶1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidinedione, xestospongin C and losartan, were purchased from Sigma. SKF96365∶1-[β-(3-(4-Methoxyphenyl) propoxy)-4-methoxyphenethyl]-1H-imidazole hydrochloride, 1-[2-(4-Methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl]imidazole and cannabidiol were purchased from Tocris Bioscience.

Small Interfering RNA

A mixture of three different small interfering RNAs (siRNA) were designed in duplexes of 25 nucleotides and synthesized by Invitrogen (Invitrogen, Paisley, UK). All three sense strands of the siRNA used to silence the porcine TRPV2 gene contained Alexa488 fluorescent dye. The three sense oligonucleotides are: 5′-Alexa 488-CACUGAGCUGGUGACCCUGAUGUAU-3′; 5′-Alexa 488-AGGUUCCUCAUCAACUUCCUGUGUU-3; 5′-Alexa 488-ACCUCCUUCGUGGACAGCUACUUUG-3′. A scrambled sequence siRNA double-stranded oligomer not homologous to any known gene (fluorescent Alexa 488-coupled oligonucleotide) served as a control. Transfection of primary porcine RPE cells was carried out 1 week after seeding using a lipophilic transfection reagent (Lipofectamine 2000, Invitrogen) in Opti-MEM. After 24–48 h, cells were used for patch clamping, Ca2+imaging or protein isolation.

Measurements of Intracellular Free Ca2+

Measurements of intracellular free Ca2+were performed as we previously described [7]. TRPV2-RNAi or mock transfected cells were loaded with 5 µM fura-2 AM and transferred to a shallow recording chamber on stage of an inverted fluorescence microscope, Zeiss Axiovert 40 CFL (Carl Zeiss Göttingen, Germany) in conjunction with a Visitron Polychromator-System (Puchheim, Germany), equipped with Ca2+imaging system and continuously superfused with Ringeŕs solution. For Ca2+measurements, fluorescence was elicited at 340 nm and 380 nm excitation wavelengths, emission was filtered with a 510 nm filter and detected by a cooled charged-coupled device camera (CoolSnap, Visitron Systems, Puchheim, Germany). Data were collected and analyzed with MetaFlour software (Visitron Systems, Puchheim, Germany). We identified transfected cells by the expression of the fluorescent Alexa 488-coupled oligonucleotide and the given image was combined with the corresponding fura-2 AM image using ImageJ 1.44p software (National Institutes of Healths, USA) for data analysis. Cells were stimulated during 80 seconds by bath perfusion of 100 nM AngII or with different blockers. The ratio of F340/F380 was converted to approximate [Ca2+]i as described by [37] using a fura-2 calibration. All experiments were conducted at room temperature.

Statistical Analysis

Statistical significance for all calcium experiments was tested using ANOVA with Tukey’s multiple comparison post test. Statistical analysis using paired Student’s t tests was applied to determine whether densitometry measurements of western blot following a given treatment (mock or RNAi treatment) were significant. Data presented in bar graph shows mean ± SEM, p<0.05 was accepted as significant. n = number of cells from 4–9 (for poricine) or 9–16 (for mouse), independent experiments = cell cultures). The n-number were handled as individual cells because there was no indication that AngII-evoked Ca2+-raises spread among the cells due to gap-junction coupling. Only individual cells in a mono layer have responded to the AngII applications.

Results

AngII-evoked Ca2+Signaling in the RPE

In a recent study we showed that cultured porcine RPE (pRPE) represent a reliable model to study AngII signaling in the RPE [7]. In particular, as it is shown in Fig. 1A, freshly isolated pRPE cells form a tight and pigmented monolayer resembling the native architecture of the retinal epithelium. In addition, these cells showed a robust expression of AT1R and Atrap as demonstrated by RT-PCR (Fig. 1B). Application of AngII (100 nM) led to an increase in intracellular free Ca2+(Fig. 1C and 1D) which lasted longer than the application period of AngII resulting in a delayed recovery phase. Quantifications of the intracellular Ca2+concentration were performed at the resting (before AngII application), peak (during AngII) and 60 s after the Ca2+-peak (delayed recovery phase) for all the experiments. In all control experiments, as they will be shown later on (non-transfected and transfected porcine or non-transfected mouse RPE cells) at 60 s after the Ca2+-peak, the intracellular calcium differed to the resting Ca2+by 23–50 nM (p>0.05). In order to have an internal control for each cell in experiments using different blockers, we used an experimental paradigm consisting of a double application of AngII in sequence. Control experiments were performed to show that repeated AngII stimulation for 80 seconds leads to comparable Ca2+transients. Application of AngII at 100 nM to pRPE cells with 7 minutes of wash out between applications (until [Ca2+]i returned back to the resting level) led to transient rise in [Ca2+]i concentration (Fig. 1C and D). Importantly, the AngII-evoked calcium mobilization in pRPE was due to specific activation of AT1 receptor by AngII, since bath application of the AT1 receptor blocker losartan at 10 µM abolished the AngII-induced calcium increase in pRPE (Fig. 1E and F).

thumbnail
Download:
Figure 1. Porcine RPE cells constitute a suitable model to study AngII-evoked Ca2+

response. A: Freshly isolated porcine RPE (pRPE) in culture formed a pigmented monolayer. Scale bar, 40 µm. B: RT-PCR using mRNA from cultured pRPE cells expressed both Atrap (182 bp) and AT1R (203 bp), GAPDH (340 bp) was used as control. C: Bath application of AngII at 100 nM for 80 seconds (bars) evoked Ca2+responses in a pRPE cell. In the same cell, after washing out 100 nM AngII (until [Ca2+]I returned back to resting levels) further application of AngII led to a second rise in [Ca2+]i. D: Summary of data from experiments shown in C. E: Losartan at 10 µM inhibited AngII-evoked Ca2+responses in pRPE cells. On the left panel it is shown the effect of AngII application under control conditions. In the same cell, after washing out AngII (until [Ca2+]I returned back to resting levels) AngII was applied in the presence of losartan (right panel). The wash out is not shown and the x-axis is interrupted accordingly between the panels. Note that losartan itself led to an increase in intracellular free Ca2+. F: Summary of data from experiments shown in E. Bars in Fig. 1D and F represent means ± SEM for AngII-evoked Ca2+responses before (open bars) during the peak (black bars) and at 60 s after the maximum AngII-elicited calcium response (gray bars). * p<0.05, (***; ###) p<0.0001; repeated measures ANOVA. n = number of cells from 4 (D) or 7 (F) independent experiments.

https://doi.org/10.1371/journal.pone.0049624.g001

The transient calcium response triggered by AngII stimulation might be the result of Ca2+release from the endoplasmic reticulum (ER), and the subsequent sustained Ca2+entry from the extracellular compartment or a combination of both [38], [39]. The contribution of each of these pathways was tested in the porcine RPE model. In these experiments AngII was applied first alone and after wash out until [Ca2+]i has returned back to the resting level, then AngII was applied a second time in the presence of a blocker for these two pathways. Perfusion of the phospholipase C (PLC) blocker U73122 (10 µM) completely inhibited the AngII-dependent calcium increase observed in pRPE (Fig. 2A and B). Unlike U73122, application of the inactive analog U73343 at 10 µM did not affect the AngII-evoked calcium response (Fig. S1). In addition, application of 1 µM of xestospongin C, a selective and reversible blocker of inositol-1,4,5-trisphosphate (IP3) receptor, reduced the AngII-induced Ca2+response in pRPE cells (Fig. 2 C and D).

thumbnail
Download:
Figure 2. AngII-evoked Ca2+ response is mediated by PLC/IP3 pathway in porcine RPE cells.

Application of AngII for 80 seconds (bars) caused transient Ca2+response in pRPE cells. A: Bath application of 100 nM AngII (bars) together with 10 µM U73122 (gray shadow), a phospholipase C (PLC) blocker abolished AngII-evoked Ca2+signal in pRPE cells. On the left panels of Figures A and C, it is shown the effect of AngII application under control conditions. In the same cell, after washing out first AngII application (until [Ca2+]I returned back to basal levels) it was further perfused 100 nM of AngII in the presence of U73122 (right panel in A) or xest C (right panel in C). The wash out is not shown and the x-axis is interrupted accordingly between the panels. Note that application of U73122 alone led to a slight increase in intracellular free Ca2+. B: summary of data from experiments shown in A. C: Co-application of 100 nM AngII (bar) with the IP3 blocker xestospongin C (xest C) (gray shadow) at 10 µM reduced AngII-evoked Ca2+response in pRPE cells. D: summary of data from experiments shown in C. Bars in Fig. 2B and D represent means ± SEM for AngII-evoked Ca2+responses before (open bars) during the peak (black bars) and at 60 s after the maximum AngII-elicited calcium response (gray bars). *p<0.05, (***; ###) p<0.0001; repeated measures ANOVA. n = number of cells from 4 (B) or 5 (D) independent experiments.

https://doi.org/10.1371/journal.pone.0049624.g002

Involvement of Angiotensin-receptor-associated Protein (Atrap)

Atrap protein interacts directly with angiotensin-II type 1 receptor (AT1R) [40], playing a role in the underlying AngII-stimulated signal transduction cascades. Due to the lack of both pharmacological blockers for porcine Atrap and a gene sequence database to design siRNA capable of silencing porcine Atrap, we used a knock-out mouse model for Atrap to study the role of this protein in the AngII-stimulated Ca2+-signals in the RPE. We detected the expression of the two AT1 receptor paralogs (AT1R 1A and AT1R 1B) by RT-PCR in isolated mouse (Atrap+/+and Atrap−/−) RPE cells (Fig. 3A) and Atrap protein (Fig. 3B) in isolated mouse wild type RPE cells. By means of RT-PCR in isolated mouse (Atrap+/+) RPE cells, we detected the expression of the two AT1 receptor paralogs (AT1R 1A and AT1R 1B) (Fig. 3A) and also a robust expression of Atrap (Fig. 3B). Moreover, AT1R and Atrap proteins were detected by western blotting as shown in (Fig. 3C). AT1R expression was also demonstrated by immunohistochemistry in RPE cells from both wild type (Atrap+/+) and Atrap-deficient (Atrap−/−) mice (Fig. 3D, left panels) while Atrap protein expression was detected in the outer plexiform layer and in the RPE from Atrap+/+mice (Fig. 3D, right panels). Notably, AT1R and Atrap were both expressed at or near the basolateral membrane of the RPE (Fig. 1D insets) in the wild-type mouse. Atrap staining was also visible at the apical membrane of the RPE. In order to study the AngII-evoked calcium transients, we cultured RPE cells isolated from Atrap+/+and Atrap−/− mice and measured the AngII-evoked calcium mobilization using the Ca2+indicator fura-2 AM. Bath application of 100 nM AngII increased the intracellular calcium concentration [Ca2+]i with an initial peak followed by a delayed recovery phase in Atrap+/+RPE cells, whereas in Atrap−/− RPE cells, the peak was smaller with the sustained component concomitantly smaller (Fig. 3E and F). Remarkably, the wild-type mouse RPE cells showed a different behavior of the AngII-evoked Ca2+response compared to that in the porcine cells. In the mouse cells a second rise of intracellular free Ca2+occurred two minutes after AngII application. Since it is likely that it is a species difference we did not further investigate this effect. When comparing the AngII responses in the mouse RPE cells, we found that Ca2+levels rose from a resting concentration of 57.13±5.55 nM to a peak of 185.46±34.03 nM in wild-type cells, in contrast to a resting Ca2+concentration of 47.72±3.55 nM to a peak of 128.94±14.03 nM in Atrap−/− mouse cells. The increase in concentration was significantly greater in wild-type cells (Fig. 3E).

thumbnail
Download:
Figure 3. Lack of Atrap reduces AngII-mediated Ca2+ signaling in mouse RPE cells.

RT-PCR from freshly isolated mouse Atrap+/+RPE cells shows expression of both AT1 receptor paralogs (AT1R 1A and AT1R 1B; 565 bp) (A) and Atrap; 194 bp (B). βactin mRNA (540 bp) from retinal and kidney tissues served as control. C: Western Blot analysis indicates the expression of both AT1R and Atrap in mouse RPE cells. D: Immunostaining of Atrap+/+and Atrap−/− mouse retinas using antibodies against AT1R (arrows, left panels) and Atrap (arrows, right panels). Insets represent an enlarged confocal area around the arrows, indicating basolateral localization of AT1R (arrowheads, upper left panel) and Atrap (arrowheads, upper right panel) at both the basolateral and the apical side. Differential Interference Contrast (DIC) image illustrates the retinal layers as outer plexiform layer (OPL), outer nuclear layer (ONL) and retinal pigment epithelium (RPE). E: Traces show transient Ca2+response from Atrap+/+(mean, white line; SEM in black) and Atrap−/− (mean, black line; SEM in gray) RPE cells upon 80 seconds AngII (100 nM) stimulation (bars). AngII-evoked Ca2+response was smaller in Atrap−/− mouse cells than that from Atrap+/+. F: Summary of data from experiments shown in E. Bars in Fig. 3F represent means ± SEM for AngII-evoked responses before (open bars) during the peak (black bars) and at 60 s after the maximum AngII-elicited calcium response (gray bars). (*; #) p<0.05; ANOVA analysis. n = number of cells from 15 independent experiments.

https://doi.org/10.1371/journal.pone.0049624.g003

Functional Expression of TRPV2 Channels in the Porcine RPE Cells

When compared to wild type (Atrap+/+), RPE cells from Atrap−/− mouse showed two main features in the AngII-evoked Ca2+signals: a reduced initial peak and sustained component remarkably smaller. Classical Ca2+signals elicited from G protein-coupled receptors comprises an initial peak that results from the release of Ca2+from the cytosolic stores, while the subsequently occurring phase results from the influx of extracellular Ca2+into the cell. In the next step we aimed to identify the molecular entity contributing to the delayed recovery phase which, most likely, results from activation of Ca2+-conducting ion channels. Human RPE cells express functional IGF-1 receptor-activated TRPV2 channels [33] which are also known to be activated by G protein-coupled receptors. Along this line, TRPV2 channels appeared as possible candidates to contribute to the delayed recovery phase of AngII-evoked Ca2+rises in the RPE cells. With RT-PCR we found that porcine RPE cells also express TRPV2 channels (Fig. 4A). In order to show the functional expression of TRPV2 channel in pRPE cells, we analyzed the Ca2+response to cannabidiol (a TRPV channel activator) and SKF96365 (a TRPV channel inhibitor). This was done in two separated set of experiments. In one cannabidiol was applied alone and in the second set cannabidiol was applied in the presence of SKF96365. Application of 15 µM cannabidiol, a broad range TRPV channel opener [41], rose the intracellular free Ca2+from a resting concentration of 93.6±11.9 nM to a peak of 648.1±61.8 nM (Fig. 4B and C, left). Importantly, pre-incubating the cells with the TRPV2 inhibitor SKF96365 at100 µM, reduced the cannabidiol-evoked Ca2+rise by 48.61% (from a resting concentration of 81.6±7.7 nM to a peak of 369.1±42.9 nM ) when compared to control (Fig. 4B and C). Next we tested the effect of SKF96365 on AngII-induced Ca2+transients. In these experiments AngII was applied first alone and after wash out until [Ca2+]i has returned back to the resting level, then AngII was applied a second time in the presence of SKF96365. SKF96365 at 100 µM abolished the AngII-evoked Ca2+rise (Fig. 4 D and E), again suggesting that TRPV2 plays a role in the AngII-evoked Ca2+signaling in pRPE cells (delayed recovery phase control: 125.9±17.9 nM and delayed recovery phase with SKF96365∶63.2±8.5 nM). In summary, this pharmacologic profile suggests that porcine RPE cells express functional SKF96365-sensitive TRPV2 channels likely contributing to the delay in recovery phase of AngII-induced Ca2+rises.

thumbnail
Download:
Figure 4. TRPV2 channels is present in porcine RPE cells.

A: RT-PCR using mRNA from cultured porcine (pRPE) cells. mRNA from retinal and lung tissues were used as control. Porcine RPE robustly expressed TRPV2 (343 bp). B: left panel, 15 µM cannabidiol (CBD) was applied for a period of 10 min (bars) where it caused a reversible Ca2+response in a pRPE cell. Right panel: Bath application of 15 µM CBD (bar) together with 100 µM SKF96365, a TRPV channel inhibitor (gray shadow) reduced the CBD-evoked Ca2+signal in another pRPE cell. C: summary of data from experiments shown in B. D: Application of AngII for 80 seconds (bars) caused transient Ca2+response in a pRPE cell. In the same cell, after washing out AngII until [Ca2+]I returned back to resting levels, AngII-mediated Ca2+signal was prevented by application of 100 µM SKF96365 (gray shadow). Note the wash out is not shown and the x-axis is interrupted accordingly between the panels. E: summary of data from experiments shown in D. Bars in Fig. 4C and E represent respectively means ± SEM for CBD- or AngII-evoked Ca2+responses before (open bars) during the peak (black bars) and at 60 s after the maximum AngII-elicited calcium response (gray bars). (**; ##) p<0.001, (***; ###) p<0.0001; repeated measures ANOVA. n = number of cells from 5 (C) or 6 (E) independent experiments.

https://doi.org/10.1371/journal.pone.0049624.g004

Contribution of TRPV2 to Ca2+Entry Upon AngII Stimulation

Although the pharmacology approach we used here strongly suggests that TRP channels are responsible for generating the sustained Ca2+rise upon AngII stimulation, concerns about the low specificity of the blocker may still exit. In order to prove this more conclusively, we used RNAi approach against TRPV2.

The RNAi specifically targeting TRPV2 (TRPV2-RNAi) reduced endogenous TRPV2 channel protein levels to about 55% (green bar) of those in mock transfected cells (gray bar), according to densitometry analysis (Fig. 5B) of western blots (Fig. 5A). We measured the intracellular calcium response elicited by AngII in pRPE cells transfected with fluorescence-tagged TRPV2-RNAi and compared with non-transfected or fluorescence-tagged mock transfected cells using the Ca2+indicator fura-2 AM (Fig. 5C: green dots are fluorescence-tagged TRPV2-RNAi cells loaded with fura-2 AM in red). Using this technique, AngII-evoked Ca2+rises in TRPV2-RNAi loaded cells could be compared with non-transfected cells at the same time. The same was done in control experiments with mock transfection. Thus the effect of TRPV2 knock-down was simultaneously analyzed against two controls: non-transfected and mock-transfected cells. The Ca2+peak response to 100 nM AngII was similar, in size and shape, in these three groups (Fig. 5D). However, the sustained Ca2+phase (delayed recovery phase ) in TRPV2-RNAi cells occurring 60 seconds after the peak AngII-response (arrows) was significantly reduced when compared with non-transfected or mock transfected cells (Fig. 5D and E, green). Sixty seconds after the maximum AngII-elicited calcium response (arrows), mock or non-transfected cells had comparable cytosolic Ca2+levels (delayed recovery phase), which were much higher than those observed for TRPV2-RNAi treated cells at 60 seconds (Fig. 5D and E). Together, these findings indicate that TRPV2 channel is involved in the AngII-evoked calcium response in porcine RPE cells.

thumbnail
Download:
Figure 5. AngII-evoked Ca2+ response is mediated by TRPV2-dependent Ca2+ influx in porcine RPE cells.

A: Western blot analysis indicated successful suppression of TRPV2 channel by RNAi. Transfection with mock RNA served as control. B: Densitometry analysis of each lane in the western blot shown in A. TRPV2- RNAi treated cells (green) showed a down-regulation of TRPV2 protein in about 55% compared to mock transfected cells (gray). TRPV2 bands in each group (mock and RNAi) were normalized to actin. Bars represent means ± SEM; * p<0.05, paired t test. Densitometry analysis results from 3 different blots; n = 3. C: Representative Fura 2-AM loaded cells (in red) and cells transfected with either TRPV2-RNAi or mock RNA- bound to Alexa 488 fluorescent dye (green dots) (see methods). Scale bar, 30 µm. D: TRPV2-RNAi treated cells (green trace) showed a quick reduction (within 60 s, arrow) of AngII-evoked Ca2+(bar) elevation when compared to non-transfected (black trace) or mock-transfected cells (gray trace). Application of AngII at 100 nM for 80 seconds (bar) evokes similar Ca2+responses in mock (gray trace) or non-transfected (black trace) porcine RPE cells. Transfection with mock RNA (gray trace) did not alter the sustained AngII-evoked Ca2+elevation (delayed recovery phase) as TRPV2-RNAi did. Sixty seconds after the maximum AngII-elicited calcium response is shown by arrows. E: Summary of data from experiments shown in D. Black (for non-transfected cells), green (for TRPV2-RNAi) and gray (for mock) transfected cells. Bars represent means ± SEM of the difference between AngII-evoked Ca2+signal at the peak and 60 seconds after the peak respectively. (**) p<0.001; repeated measures ANOVA. n.s = not significant. n = number of cells from 26–41 (E) independent experiments. A: Application of AngII (100 nM) for 80 seconds (bars) caused transient Ca2+response in pRPE cells. Bath application of 100 nM AngII (bars) produced a Ca2+response that was not abolished by co-application of 10 µM U73343 (gray shadow), the inactive analog of the phospholipase C (PLC) blocker U73122. B: summary of data from experiments shown in A. Bars in Fig. 2B represent means ± SEM for AngII-evoked Ca2+responses before (open bars) during the peak (black bars) and at 60 s after the maximum AngII-elicited calcium response (gray bars). (*; #) p<0.05, ** p<0.0001; repeated measures ANOVA. n = number of cells from 9 independent experiments.

https://doi.org/10.1371/journal.pone.0049624.g005

Discussion

The present study was performed to evaluate the calcium signaling pathway triggered by AngII in the RPE. The most remarkable result presented here is that AngII-dependent Ca2+responses in the RPE involves both calcium mobilization from intracellular stores and extracellular Ca2+entry, most likely through TRPV2 channel activation. Furthermore, a new role of Atrap for AngII-dependent Ca2+-signalling was found in the RPE.

Milenkovic et al. (2010) reported recently that systemic infusion of AngII into mice caused a significant decrease in renin expression in the kidney and a reduction of the renin mRNA levels in both RPE cells and neuronal retina, whereas systemic application of ACE inhibitor increased the renin expression in the RPE by 20-fold [7]. Since previous studies showed that AngII from the plasma cannot enter the eye [24], it was suggested that systemic AngII modulates local intraocular renin production through AT1R activation in the RPE [7]. In order to analyze the molecular mechanism contributing to the signaling cascade leading to AngII-mediated effects, we performed Ca2+-imaging experiments. As we have reported previously cultured pRPE cells showed biphasic increases in intracellular free Ca2+upon stimulation by AngII. Since in the presence of the specific AT1R blocker losartan AngII failed to evoke Ca2+transients, the AngII-stimulated effect was due to specific activation of AT1R receptors and not AT2 receptors, which is in accordance with previously published data [7].

Our study shows that AngII stimulation of AT1R receptor leads to release of Ca2+from the ER through the activation of PLC and concomitant generation of IP3. Incubation with the PLC blocker U73122 completely abolished the AngII Ca2+response and inhibition of calcium release by using the IP3R blocker xestospongine C also prevented the calcium rise evoked by AngII. In agreement with our finding, Fellner and Arendshorst (2005), using calcium imaging techniques on isolated afferent arterioles reported that the peak response to AngII was attenuated by inhibiting the IP3 receptors with 8-(N,N-diethylamino) octyl 3,4,5-trimethoxybenzoate (TMB). These IP3R blockers also inhibited AngII-mediated AT1R induced calcium release from the ER through PLC/IP3 pathways in preglomerular renal vascular smooth muscle cells [42]. In addition, there is functional evidence in support of Ca2+mobilization in vivo, since TMB decreased AngII-dependent renal vasoconstriction [43]. Praddaude et al. (2009), using calcium imaging on mouse RPE sheets, showed that AngII stimulation of AT1R also increases [Ca2+]i in a biphasic manner, with both an initial peak and plateau phase. Thus in the RPE as in other AngII sensitive cells the AngII-dependent rise of [Ca2+]i depends on release of Ca2+from cytosolic stores.

Since Atrap is a protein bound to the AT1R, it is possible that Atrap is involved in the ignition of the cascade of AT1R signaling in the RPE. We found that mouse RPE cells in situ and in vitro and porcine RPE in vitro express Atrap. Both AT1R and Atrap were found at the basolateral membrane of the RPE in the wild-type. This implies a functional association of the proteins. However, a proportion of Atrap was also found at the apical membrane of the RPE which implies possible functions of Atrap other than AngII-signaling. Atrap−/− mice demonstrated AT1R expression as it was shown by immunohistochemistry on retina sections. In addition to that cultured RPE cells from Atrap−/− mice show AngII-evoked Ca2+responses which prove that the functional expression of AT1R is maintained in the cell culture. Thus, we can use mouse RPE cells to study AngII-mediated Ca2+transients in the absence of Atrap. Also in the mouse RPE, AngII led to a biphasic increase in intracellular Ca2+, which consists of an initial peak followed by sustained phases. We found that Atrap−/− RPE cells showed a smaller Ca2+peak and a smaller intracellular Ca2+during the recovery phase (measured at 60 s), which implies that Atrap plays a role in mediating the different events of AngII-mediated Ca2+signaling. This observation points to a new function of Atrap. Atrap had been considered to be a negative regulator of the surface expression of AT1R [20]. This does not seem to be the case in RPE cells, at least as shown by the similar staining of AT1R in both wild-type and Atrap−/− retina sections. The smaller Ca2+signals would indicate more likely a role as a positive regulator of AT1R-mediated signaling cascade. Due to the limited material of the RPE cells in mice it was not possible to measure the AT1R surface expression in wild-type and Atrap knock-out mice. Because the absence of Atrap reduces the Ca2+peak, Atrap might directly influence the mechanism of Ca2+signaling, perhaps by depleting cytosolic Ca2+stores. However, without knowing other proteins with which Atrap might interact it is uncertain what the nature of this influence might be and in which parts of the signaling pathway Atrap might be involved in.

In general, less well understood are the mechanisms involved in the activation of Ca2+entry pathways following stimulation by AngII that generate a plateau phase, both in RPE cells and in other cell types. In renal vascular smooth muscle cells, removal of extracellular Ca2+attenuated the AngII-mediated peak response to about 50% of the control value, with the remaining proportion likely stemming from intracellular stores [42]. The discussion above implicates that the plateau phase of the AngII-evoked Ca2+transients likely results from a Ca2+influx into the cell through activation of Ca2+conducting ion channels. It has been long known that many TRP channels can be stimulated subsequent to PLC activation by G protein-coupled receptors, by accumulation of DAG in the membrane after PLC activation, by tyrosine kinase receptors, or by intracellular Ca2+directly, this last feature a property of the majority of these ion channels [44]. Freshly isolated human RPE cells and ARPE-19 cells express TRPV1, 2, 3 and 4 [33] and possibly TRPV5 and 6 [45]. Among those, TRPV2 was found to be functionally expressed. TRPV2 is regulated by heat, growth factors, and other ligands [33], [46]–[49]. Indeed, the study from Monet et al. (2009) using pertussis-toxin (a Gi and Go-protein blocker) in CHO and HEK cells suggested that lysophosphatydilcholine-(LPC) dependent TRPV2 activation is mediated by G-protein pathways. In the human RPE, functional expression of TRPV2 channels has also been shown [33]. Thus, it is likely that in the RPE a comparable mechanism couples the activation of AT1R with the generation of a delayed recovery phase through activation of TRPV2 channels. In order to test this hypothesis we first checked whether porcine RPE cells functionally express TRPV2 by pharmacological means. Application of cannabidiol strongly increases intracellular Ca2+in porcine RPE cells. Although cannabidiol is known to activate TRPV1,2,3 and 4, it is more selective to TRPV2 [41], [50]–[53]. Importantly, SKF96365, a blocker of TRPV2 channels, reduced cannabidiol-evoked Ca2+signaling. SKF96365 is known to block TRPC channels, T-type Ca2+channels and TRPV2 channels [54]–[58]. Among these Ca2+channels only TRPV2 is known to be activated by cannabidiol. Thus, this experiment clearly demonstrates the functional presence of TRPV2 channels in porcine RPE cells. However, the cannabidiol response was not fully blocked by SKF96365. This can be explained by the fact that the RPE also express the TRPV 1, 3 and 4 channels which are also known to be activated by cannabidiol. It is likely that the SKF96365-insensitive part of the cannabidiol response is due the activation of TRPV1, 3 or 4 channels.

Based on the pharmacologic analysis discussed above SKF96365 was used to gain insight to whether TRPV2 channels might contribute to the delayed recovery phase of AngII-evoked Ca2+rises. Indeed, SKF96365 prevented the AngII-evoked Ca2+response in pRPE which strongly reinforces the concept of a role for Ca2+entry from the extracellular compartments and implies a contribution of TRPV2 channels. However, nothing has been previously reported about TRPV2 channel activation by AngII. Because both mRNA and protein TRPV2 were shown to be expressed in pRPE cells, we investigated the implications of TRPV2 activation on the AngII-mediated Ca2+signaling in RPE cells by means of RNAi techniques. Our calcium imaging data clearly show that knockdown of endogenous TRPV2 channels with TRPV2-RNAi strongly reduced the delay in the recovery phase AngII-mediated Ca2+response (later 60 seconds after the peak burst) and showed the same magnitude as in SKF96365-treated cells. Thus, the remaining Ca2+elicited after AngII stimulation in RNAi treated cells very likely comes from Ca2+release from the stores. This observation strongly indicates that TRPV2 contributes to the AngII-induced Ca2+entry in the RPE.

The AngII signaling at the RPE is of importance to understand inflammatory and/or neovascular diseases of the retina. In recent years the effects of AngII signaling in diseases such as diabetic retinopathy or age-related macular degeneration has gained increasing attention [8], [10]–[17], [59]–[61]. The discovery of a local renin-angiotensin system in the retina has opened new ways of understanding patho-physiological processes leading to inflammation or neovascularisation [8]. The local AngII and AT1R signaling was found to participate in these processes. However, recent observations point also to the participation of AT2R and AngI reaction products such as Ang1-7 [8], [59]. The latter appeared to show anti-inflammatory and anti-angiogenic effects. Thus the exploration of the local renin-angiotensin system of the retina will open new ways in the development of therapies. However, in contrast to these promising observations the systemic application of drugs which modulate the renin-angiotensin system did not show the expected effects or even adverse effects [62]. One reason might be the AngII signaling at the RPE. The RPE is able to react upon changes in the AngII levels in the plasma via basolateral AT1R [7] and possible through the connected signaling via Atrap and TRPV2 channels. This AngII signaling pathway leads to a reduced renin production by the RPE and decreased renin activity in the retina [7]. Thus the AngII signaling at the RPE connects the local renin-angiotensin system with systemic renin-angiotensin system. This understanding is of utmost importance to develop therapies which target the local renin-angiotensin system of the retina.

In summary the following picture of AT1R signaling in RPE cells emerges from our data. Activation of AT1R leads to an increase in intracellular free Ca2+by activation of PLC and subsequent release of Ca2+from intracellular Ca2+stores via activation of IP3-receptors. This leads to an initial peak of the Ca2+response followed by a Ca2+influx into the cell through TRPV2 channels, which yields a sustained Ca2+increase. The generation of the initial peak and the sustained response requires the activation of Atrap. In particular, the sustained Ca2+response requires the presence of Atrap, as suggested by the fact that it was almost abolished in RPE cells from Atrap knock-out mice. This also appears to be the first physiological demonstration of a role of TRPV2 in the intraocular RAS. Together, our results constitute a significant and novel addition to our understanding regarding how the systemic RAS interacts with the RAS in the eye.

Supporting Information

Figure S1.

Effect of U73343, the inactive analof of U73122, on AngII-evoked Ca2+response. A: Application of AngII (100 nM) for 80 seconds (bars) caused transient Ca2+response in pRPE cells. Bath application of 100 nM AngII (bars) produced a Ca2+response that was not abolished by co-application of 10 µM U73343 (gray shadow), the inactive analog of the phospholipase C (PLC) blocker U73122. B: summary of data from experiments shown in A. Bars in Fig. 2B represent means ± SEM for AngII-evoked Ca2+responses before (open bars) during the peak (black bars) and at 60 s after the maximum AngII-elicited calcium response (gray bars). (*; #) p<0.05, ** p<0.0001; repeated measures ANOVA. n = number of cells from 9 independent experiments.

https://doi.org/10.1371/journal.pone.0049624.s001

(TIF)

Acknowledgments

The authors want to acknowledge the technical assistance of Elfriede Eckert and Andrea Dannullis. We also acknowledge the expert technical assistance of Uwe DeVries for his help with the confocal microscope. We thank Prof. Dr. Kenneth J. Muller for comments and suggestions on the manuscript. The work was supported by the Deutsche Forschungsgemeinschaft grant (DFG SFB699 project B8). There are no commercial interests or conflicts of interest.

Author Contributions

Conceived and designed the experiments: RB-S VT HC OS. Performed the experiments: RB-S JS CM RF. Analyzed the data: RB-S JS OS. Contributed reagents/materials/analysis tools: VT HC. Wrote the paper: RB-S OS.

References

  1. 1. Rong P, Wilkinson-Berka JL, Skinner SL (2001) Control of renin secretion from adrenal gland in transgenic Ren-2 and normal rats. Mol Cell Endocrinol 173: 203–212.
  2. 2. Wilkinson-Berka JL, Kelly DJ, Rong P, Campbell DJ, Skinner SL (2002) Characterisation of a thymic renin-angiotensin system in the transgenic m(Ren-2)27 rat. Mol Cell Endocrinol 194: 201–209.
  3. 3. Berka JL, Stubbs AJ, Wang DZ, DiNicolantonio R, Alcorn D, et al. (1995) Renin-containing Muller cells of the retina display endocrine features. Invest Ophthalmol Vis Sci 36: 1450–1458.
  4. 4. Sarlos S, Rizkalla B, Moravski CJ, Cao Z, Cooper ME, et al. (2003) Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. Am J Pathol 163: 879–887.
  5. 5. Senanayake P, Drazba J, Shadrach K, Milsted A, Rungger-Brandle E, et al. (2007) Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci 48: 3301–3311.
  6. 6. Downie LE, Vessey K, Miller A, Ward MM, Pianta MJ, et al. (2009) Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina. Neuroscience 161: 195–213.
  7. 7. Milenkovic VM, Brockmann M, Meyer C, Desch M, Schweda F, et al. (2010) Regulation of the renin expression in the retinal pigment epithelium by systemic stimuli. Am J Physiol Renal Physiol 299: F396–F403.
  8. 8. Fletcher EL, Phipps JA, Ward MM, Vessey KA, Wilkinson-Berka JL (2010) The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature. Prog Retin Eye Res 29: 284–311.
  9. 9. Wagner J, Jan Danser AH, Derkx FH, de Jong TV, Paul M, et al. (1996) Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 80: 159–163.
  10. 10. Wilkinson-Berka JL, Tan G, Jaworski K, Ninkovic S (2007) Valsartan but not atenolol improves vascular pathology in diabetic Ren-2 rat retina. Am J Hypertens 20: 423–430.
  11. 11. Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, et al. (2009) Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361: 40–51.
  12. 12. Moravski CJ, Kelly DJ, Cooper ME, Gilbert RE, Bertram JF, et al. (2000) Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension 36: 1099–1104.
  13. 13. Nagai N, Noda K, Urano T, Kubota Y, Shinoda H, et al. (2005) Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci 46: 1078–1084.
  14. 14. Downie LE, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL (2008) AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy. Glia 56: 1076–1090.
  15. 15. Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, et al. (2007) Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Invest Ophthalmol Vis Sci 48: 2321–2326.
  16. 16. Striker GE, Praddaude F, Alcazar O, Cousins SW, Marin-Castano ME (2008) Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II. Am J Physiol Cell Physiol 295: C1633–C1646.
  17. 17. Praddaude F, Cousins SW, Pecher C, Marin-Castano ME (2009) Angiotensin II-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium. Exp Eye Res 89: 109–118.
  18. 18. Daviet L, Lehtonen JY, Tamura K, Griese DP, Horiuchi M, et al. (1999) Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem 274: 17058–17062.
  19. 19. Tanaka Y, Tamura K, Koide Y, Sakai M, Tsurumi Y, et al. (2005) The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy. FEBS Lett 579: 1579–1586.
  20. 20. Oppermann M, Gess B, Schweda F, Castrop H (2010) Atrap deficiency increases arterial blood pressure and plasma volume. J Am Soc Nephrol 21: 468–477.
  21. 21. Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85: 845–881.
  22. 22. Jacobi PC, Osswald H, Jurklies B, Zrenner E (1994) Neuromodulatory effects of the renin-angiotensin system on the cat electroretinogram. Invest Ophthalmol Vis Sci 35: 973–980.
  23. 23. Jurklies B, Eckstein A, Jacobi P, Kohler K, Risler T, et al. (1995) The renin-angiotensin system–a possible neuromodulator in the human retina? Ger J Ophthalmol 4: 144–150.
  24. 24. Danser AH, Derkx FH, Admiraal PJ, Deinum J, de Jong PT, et al. (1994) Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 35: 1008–1018.
  25. 25. Lassegue B, Alexander RW, Clark M, Akers M, Griendling KK (1993) Phosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulated vascular smooth-muscle cells. Biochem J 292: 509–517.
  26. 26. Fellner SK, Arendshorst WJ (2005) Angiotensin II Ca2+signaling in rat afferent arterioles: stimulation of cyclic ADP ribose and IP3 pathways. Am J Physiol Renal Physiol 288: F785–F791.
  27. 27. Putney JW Jr (1990) Capacitative calcium entry revisited. Cell Calcium 11: 611–624.
  28. 28. Schweda F, Riegger GA, Kurtz A, Kramer BK (2000) Store-operated calcium influx inhibits renin secretion. Am J Physiol Renal Physiol 279: F170–F176.
  29. 29. Guenther E, Schmid S, Hewig B, Kohler K (1996) Two-fold effect of Angiotensin II on voltage-dependent calcium currents in rat retinal ganglion cells. Brain Res 718: 112–116.
  30. 30. Luckhoff A, Clapham DE (1994) Calcium channels activated by depletion of internal calcium stores in A431 cells. Biophys J 67: 177–182.
  31. 31. Wimmers S, Karl MO, Strauss O (2007) Ion channels in the RPE. Prog Retin Eye Res 26: 263–301.
  32. 32. Wimmers S, Strauss O (2007) Basal calcium entry in retinal pigment epithelial cells is mediated by TRPC channels. Invest Ophthalmol Vis Sci 48: 5767–5772.
  33. 33. Cordeiro S, Seyler S, Stindl J, Milenkovic VM, Strauss O (2010) Heat-sensitive TRPV channels in retinal pigment epithelial cells: regulation of VEGF-A secretion. Invest Ophthalmol Vis Sci 51: 6001–6008.
  34. 34. Monet M, Gkika D, Lehen’kyi V, Pourtier A, Vanden Abeele F, et al. (2009) Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim Biophys Acta 1793: 528–539.
  35. 35. Milenkovic VM, Krejcova S, Reichhart N, Wagner A, Strauss O (2011) Interaction of Bestrophin-1 and Ca Channel beta-Subunits: Identification of New Binding Domains on the Bestrophin-1 C-Terminus. PLoS One 6: e19364.
  36. 36. Neussert R, Muller C, Milenkovic VM, Strauss O (2010) The presence of bestrophin-1 modulates the Ca2+recruitment from Ca2+stores in the ER. Pflugers Arch 460: 163–175.
  37. 37. Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440–3450.
  38. 38. Schweda F, Friis U, Wagner C, Skott O, Kurtz A (2007) Renin release. Physiology (Bethesda ) 22: 310–319.
  39. 39. Chen L, Kim SM, Oppermann M, Faulhaber-Walter R, Huang Y, et al. (2007) Regulation of renin in mice with Cre recombinase-mediated deletion of G protein Gsalpha in juxtaglomerular cells. Am J Physiol Renal Physiol 292: F27–F37.
  40. 40. Lopez-Ilasaca M, Liu X, Tamura K, Dzau VJ (2003) The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell 14: 5038–5050.
  41. 41. Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, et al. (2008) TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci 28: 6231–6238.
  42. 42. Fuller AJ, Hauschild BC, Gonzalez-Villalobos R, Awayda MS, Imig JD, et al. (2005) Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol 289: F760–F767.
  43. 43. Ruan X, Arendshorst WJ (1996) Calcium entry and mobilization signaling pathways in ANG II-induced renal vasoconstriction in vivo. Am J Physiol 270: F398–F405.
  44. 44. Ramsey IS, Delling M, Clapham DE (2006) An introduction to TRP channels. Annu Rev Physiol 68: 619–647.
  45. 45. Kennedy BG, Torabi AJ, Kurzawa R, Echtenkamp SF, Mangini NJ (2010) Expression of transient receptor potential vanilloid channels TRPV5 and TRPV6 in retinal pigment epithelium. Mol Vis 16: 665–675.
  46. 46. Boels K, Glassmeier G, Herrmann D, Riedel IB, Hampe W, et al. (2001) The neuropeptide head activator induces activation and translocation of the growth-factor-regulated Ca(2+)-permeable channel GRC. J Cell Sci 114: 3599–3606.
  47. 47. Kanzaki M, Zhang YQ, Mashima H, Li L, Shibata H, et al. (1999) Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I. Nat Cell Biol 1: 165–170.
  48. 48. Nagasawa M, Nakagawa Y, Tanaka S, Kojima I (2007) Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages. J Cell Physiol 210: 692–702.
  49. 49. Stokes AJ, Shimoda LM, Koblan-Huberson M, Adra CN, Turner H (2004) A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J Exp Med 200: 137–147.
  50. 50. De Petrocellis L, Orlando P, Moriello AS, Aviello G, Stott C, et al. (2012) Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol (Oxf) 204: 255–266.
  51. 51. Hegde VL, Nagarkatti PS, Nagarkatti M (2011) Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PLoS One 6: e18281.
  52. 52. Campos AC, Guimaraes FS (2009) Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 33: 1517–1521.
  53. 53. Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, et al. (2008) TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci 28: 6231–6238.
  54. 54. Zhang D, Spielmann A, Wang L, Ding G, Huang F, et al. (2012) Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2. Physiol Res 61: 113–124.
  55. 55. Zhao H, Simasko SM (2010) Role of transient receptor potential channels in cholecystokinin-induced activation of cultured vagal afferent neurons. Endocrinology 151: 5237–5246.
  56. 56. Zhang Z, Reboreda A, Alonso A, Barker PA, Seguela P (2011) TRPC channels underlie cholinergic plateau potentials and persistent activity in entorhinal cortex. Hippocampus 21: 386–397.
  57. 57. Zanou N, Iwata Y, Schakman O, Lebacq J, Wakabayashi S, et al. (2009) Essential role of TRPV2 ion channel in the sensitivity of dystrophic muscle to eccentric contractions. FEBS Lett 583: 3600–3604.
  58. 58. Kress M, Karasek J, Ferrer-Montiel AV, Scherbakov N, Haberberger RV (2008) TRPC channels and diacylglycerol dependent calcium signaling in rat sensory neurons. Histochem Cell Biol 130: 655–667.
  59. 59. Verma A, Shan Z, Lei B, Yuan L, Liu X, et al. (2012) ACE2 and Ang-(1–7) confer protection against development of diabetic retinopathy. Mol Ther 20: 28–36.
  60. 60. Deliyanti D, Miller AG, Tan G, Binger KJ, Samson AL, et al. (2012) Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy. Hypertension 59: 607–613.
  61. 61. Wilkinson-Berka JL, Heine R, Tan G, Cooper ME, Hatzopoulos KM, et al. (2010) RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina. Hypertension 55: 1454–1460.
  62. 62. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT (2003) Epidemiology of age-related maculopathy: a review. Eur J Epidemiol 18: 845–854.